Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-23-059363
Filing Date
2023-12-20
Accepted
2023-12-20 16:54:00
Documents
1
Period of Report
2023-12-18

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 13237
  Complete submission text file 0001209191-23-059363.txt   14664
Mailing Address ONE BROADWAY, 14TH FLOOR CAMBRIDGE MA 02142
Business Address ONE BROADWAY, 14TH FLOOR CAMBRIDGE MA 02142 508-446-2272
Nuvalent, Inc. (Issuer) CIK: 0001861560 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O NUVALENT, INC. ONE BROADWAY, 14TH FLOOR CAMBRIDGE MA 02142
Business Address
Miller Deborah Ann (Reporting) CIK: 0001868741 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40671 | Film No.: 231501945